Spectral AI Completes Data Analysis for U.S. Burn Pivotal Study
Spectral AI (“Spectral AI” or the “Company”), developer of the AI-driven DeepView System, which received Breakthrough Device Designation from the U.S. Food and Drug Administration (“FDA”) in 2018 and uses...